← Open Payments lookup

EVANS AZAGIDI: Open Payments

NPI 1528530763 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,082 in 54 payments from 13 companies in 2025. Trend: 2023 $267 · 2024 $553 · 2025 $1,082

Food & beverage: $1,082
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$330
Vanda Pharmaceuticals Inc.8$145
Neurocrine BioSciences, Inc.4$102
ABBVIE INC.5$97
Janssen Pharmaceuticals, Inc3$88
E.R. Squibb & Sons, L.L.C.3$59
Alkermes, Inc.2$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$47
Supernus Pharmaceuticals, Inc.3$44
Lundbeck LLC2$42

Products named: REXULTI, FANAPT, INGREZZA, SPRAVATO, VRAYLAR, ABILIFY ASIMTUFII, COBENFY, ARISTADA.

Industry payments across NV — which companies pay providers there.